Carlyle buys stake in Piramal Pharma for Rs 3,523 cr
Updated: October 7, 2020 09:47 PM IST
Piramal Pharma Ltd (PPL) on Tuesday received Rs 3,523 crore on closure of the transaction for 20 per cent equity investment from CA Alchemy Investments, an affiliated entity of CAP V Mauritius, which is an investment fund managed and advised by affiliated entities of the Carlyle Group Inc.
